Luis A. Mendez is the Director of Flow Cytometry within the Translational Molecular Biomarkers organization at Merck & Co., where he leads the development and implementation of advanced immune profiling technologies that support the discovery of novel medicines. With more than 20 years of experience in drug discovery, translational research, and clinical development, he has contributed to programs spanning oncology, immunology, infectious diseases, and cellular therapies.
Luis holds bachelor’s degrees in Biology and Exercise Science from Rutgers University and a Master of Science in Biotechnology from Johns Hopkins University. Passionate about expanding awareness of STEM careers, he is committed to mentoring students and early-career scientists and helping inspire the next generation of STEM leaders.